Sarcopenia, a proteomics-derived sarcopenia score, and risk of incident liver outcomes: a prospective cohort study

BACKGROUND: Sarcopenia is associated with adverse outcomes in established liver disease, but its prospective associations with subsequent liver outcomes and the associated circulating proteomic features remain incompletely characterized. AIMS: To examine the prospective associations of sarcopenia with incident liver outcomes, develop a proteomics-derived sarcopenia score (ProSS), evaluate its predictive value, and explore associated biological pathways. METHODS: A two-phase analysis was conducted in the UK Biobank. In 492,305 participants, multivariable Cox models assessed the associations of sarcopenia with incident liver outcomes. In a proteomic subcohort of 51,637 participants, ProSS development and internal validation were conducted within a nested five-fold cross-validation framework incorporating multivariable screening, bootstrap-based LASSO, and elastic-net modelling. The incremental prognostic value of ProSS for MASLD and cirrhosis was evaluated using pooled out-of-fold predictions from six Cox models. Functional enrichment and exploratory single-protein indirect-effect analyses were also performed. RESULTS: During a median follow-up of approximately 14 years, sarcopenia was associated with higher risks of incident MASLD (HR 1.37, 95% CI 1.26-1.48), cirrhosis (HR 1.58, 95% CI 1.39-1.79), liver cancer (HR 1.86, 95% CI 1.37-2.52), and liver-related mortality (HR 1.91, 95% CI 1.53-2.38). In cross-validation analyses, fold-specific out-of-fold ProSS values were associated with incident MASLD (HR 1.49 per 1-SD increase, 95% CI 1.38-1.61) and cirrhosis (HR 2.39, 95% CI 2.15-2.65). Adding ProSS to a clinical model containing sarcopenia status increased the 10-year AUC from 0.765 to 0.788 for MASLD (ΔAUC 0.023, 95% CI 0.014-0.033; P<0.001) and from 0.780 to 0.846 for cirrhosis (ΔAUC 0.067, 95% CI 0.043-0.091; P<0.001). Enrichment analyses highlighted immune and inflammatory signalling, extracellular matrix organization, and cytokine/receptor-related pathways. Exploratory indirect-effect analyses highlighted GDF15, IGFBPL1, and BST2 as the leading protein signals for both MASLD and cirrhosis. CONCLUSIONS: Sarcopenia was prospectively associated with higher risks of multiple liver outcomes. ProSS provided incremental prognostic information beyond clinical factors and sarcopenia status, particularly for cirrhosis, while the associated circulating proteins may provide biological context for these associations.

Authors

Institutions

Publication Details

Journal
The journal of nutrition health & aging
Published
2026-11-17
DOI
https://doi.org/10.1016/j.jnha.2026.101029
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sarcopenia, a proteomics-derived sarcopenia score, and risk of incident liver outcomes: a prospective cohort study

Yushuang Xu, Zeyuan Diao, Na Zu, Yu Liu et al.
1 links
The journal of nutrition health & aging
Nutrition and Health in Aging
article

Sarcopenia, a proteomics-derived sarcopenia score, and risk of incident liver outcomes: a prospective cohort study

Yushuang Xu, Zeyuan Diao, Na Zu, Yu Liu, Kun Liang, RuiXue Du
article en

Abstract

BACKGROUND: Sarcopenia is associated with adverse outcomes in established liver disease, but its prospective associations with subsequent liver outcomes and the associated circulating proteomic features remain incompletely characterized. AIMS: To examine the prospective associations of sarcopenia with incident liver outcomes, develop a proteomics-derived sarcopenia score (ProSS), evaluate its predictive value, and explore associated biological pathways. METHODS: A two-phase analysis was conducted in the UK Biobank. In 492,305 participants, multivariable Cox models assessed the associations of sarcopenia with incident liver outcomes. In a proteomic subcohort of 51,637 participants, ProSS development and internal validation were conducted within a nested five-fold cross-validation framework incorporating multivariable screening, bootstrap-based LASSO, and elastic-net modelling. The incremental prognostic value of ProSS for MASLD and cirrhosis was evaluated using pooled out-of-fold predictions from six Cox models. Functional enrichment and exploratory single-protein indirect-effect analyses were also performed. RESULTS: During a median follow-up of approximately 14 years, sarcopenia was associated with higher risks of incident MASLD (HR 1.37, 95% CI 1.26-1.48), cirrhosis (HR 1.58, 95% CI 1.39-1.79), liver cancer (HR 1.86, 95% CI 1.37-2.52), and liver-related mortality (HR 1.91, 95% CI 1.53-2.38). In cross-validation analyses, fold-specific out-of-fold ProSS values were associated with incident MASLD (HR 1.49 per 1-SD increase, 95% CI 1.38-1.61) and cirrhosis (HR 2.39, 95% CI 2.15-2.65). Adding ProSS to a clinical model containing sarcopenia status increased the 10-year AUC from 0.765 to 0.788 for MASLD (ΔAUC 0.023, 95% CI 0.014-0.033; P<0.001) and from 0.780 to 0.846 for cirrhosis (ΔAUC 0.067, 95% CI 0.043-0.091; P<0.001). Enrichment analyses highlighted immune and inflammatory signalling, extracellular matrix organization, and cytokine/receptor-related pathways. Exploratory indirect-effect analyses highlighted GDF15, IGFBPL1, and BST2 as the leading protein signals for both MASLD and cirrhosis. CONCLUSIONS: Sarcopenia was prospectively associated with higher risks of multiple liver outcomes. ProSS provided incremental prognostic information beyond clinical factors and sarcopenia status, particularly for cirrhosis, while the associated circulating proteins may provide biological context for these associations.

The journal of nutrition health & agingVol. 31(2)
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN), Qingdao Municipal Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province
Good health and well-being
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon